J. Laliberté

Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes.

Y. Xiong, B. Mitchell, J. Laliberté, 1998, Blood.

Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2′-deoxycytidine by human cytidine deaminase

J. Laliberté, V. Marquez, R. Momparler, 2004, Cancer Chemotherapy and Pharmacology.

Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene.

B. Mitchell, J. Laliberté, J. Gu, 2000, The Journal of clinical investigation.

Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase.

J. Laliberté, R. Momparler, D. Bouffard, 1993, Biochemical pharmacology.

Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.

B. Mitchell, J. Laliberté, A. Zimmermann, 1998, Progress in nucleic acid research and molecular biology.

Human cytidine deaminase: purification of enzyme, cloning, and expression of its complementary DNA.

J. Laliberté, J. Laliberté, R. Momparler, 1994, Cancer research.

Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine.

J. Laliberté, R. Momparler, 1990, Leukemia research.

Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside

J. Laliberté, C. Beauséjour, R. Momparler, 1996, Anti-cancer drugs.

Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor

J. Laliberté, E. Hu, Liangfu Chen, 2020, Toxicologic pathology.